Lawrence Cher
Impact in
Papers in
- Co-authors
- Fred H. Hochberg (4 shared papers)Mark Rosenthal (24 shared papers)Jon Glass (3 shared papers)Michael L. Gruber (1 shared paper)Hui Gan (23 shared papers)Warren Mason (4 shared papers)Martin J. van den Bent (4 shared papers)Wolfgang Wick (7 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Neuro-Oncology (10 papers)Journal of Neuro-Oncology (4 papers)Journal of Clinical Neuroscience (20 papers)Neuro-Oncology Advances (2 papers)
- Partner nations
- AustraliaUnited StatesGermany
In The Last Decade
Lawrence Cher
75 papers receiving 2.9k citations
Lawrence Cher's Hit Papers
Peers
Comparison fields: 5 of 85
- Genetics 1.8k
- Neurology 988
- Cancer Research 466
- Pathology and Forensic Medicine 540
- Oncology 403
Countries citing papers authored by Lawrence Cher
This map shows the geographic impact of Lawrence Cher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Cher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Cher more than expected).
Fields of papers citing papers by Lawrence Cher
This network shows the impact of papers produced by Lawrence Cher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Cher. The network helps show where Lawrence Cher may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence Cher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma Hit paper breakdown → | 2013 | 444 |
| 2 | 2010 | 381 | |
| 3 | 1994 | 286 | |
| 4 | 2016 | 213 | |
| 5 | Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. | 2006 | 150 |
| 6 | 2015 | 122 | |
| 7 | 1996 | 122 | |
| 8 | 2009 | 121 | |
| 9 | 2011 | 105 | |
| 10 | Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. | 1996 | 85 |
| 11 | 1995 | 83 | |
| 12 | 2004 | 73 | |
| 13 | 2000 | 64 | |
| 14 | 2002 | 63 | |
| 15 | 1996 | 60 | |
| 16 | 2013 | 56 | |
| 17 | 2006 | 42 | |
| 18 | 2002 | 38 | |
| 19 | 2010 | 30 | |
| 20 | 2016 | 30 |
About Lawrence Cher
Lawrence Cher is a scholar working on Genetics, Neurology, Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology, having authored 76 papers that have together received 3.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (50 papers), Brain Metastases and Treatment (16 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Meningioma and schwannoma management (8 papers), Radiomics and Machine Learning in Medical Imaging (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Neuroblastoma Research and Treatments (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Genetics (1.8k citations), Neurology (988 citations), Cancer Research (466 citations), Pathology and Forensic Medicine (540 citations) and Oncology (403 citations). Lawrence Cher has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Fred H. Hochberg, Mark Rosenthal, Jon Glass, Michael L. Gruber, Hui Gan, Warren Mason, Martin J. van den Bent, Wolfgang Wick, Alain Carpentier and Griffith R. Harsh. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Journal of Neuro-Oncology, Journal of Clinical Neuroscience and Neuro-Oncology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.